Erratum to "Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma" [Cell. Immunol. 238 (2005) 113-122] (DOI:10.1016/j.cellimm.2006.02.007);Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma

Cellular Immunology

Volumn 238, Issue 2, 2005, Pages 113-122

  Lopez Santalla, Mercedes ^a,c   Krishnan, Sandeep ^c   Valeri, Anna P ^a   Aguilera Montilla, Noemi ^a   Fisher, Carolyn U ^c   Perez Blas, Mercedes ^a   Gutierrez Calvo, Alberto ^b   Lasa, Inmaculada ^b   Granell Vicent, Javier ^b   Tsokos, George C ^c   Martin Villa, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

CD3 ; Gastric adenocarcinoma; T lymphocytes

Indexed keywords

CD3 ANTIGEN; CD3EPSILON PROTEIN; CD3ZETA PROTEIN; CELL EXTRACT; INTERLEUKIN 2; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; CALCIUM; VIRUS PROTEIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CALCIUM MOBILIZATION; CANCER PATIENT; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID RAFT; LYMPHOCYTE CULTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; T LYMPHOCYTE; TUMOR GROWTH; WESTERN BLOTTING; ADENOCARCINOMA; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GENOME; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; STOMACH TUMOR; VIROLOGY;

SAIMIRIINE HERPESVIRUS 2;

ADENOCARCINOMA; ANTIGENS, CD3; APOPTOSIS; BASE SEQUENCE; CALCIUM; GENE EXPRESSION REGULATION, VIRAL; GENOME; HERPESVIRUS 2, SAIMIRIINE; HUMANS; INTERLEUKIN-2; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 33646072189     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2006.02.008     Document Type: Erratum

References (41)

1. Letsch A., Keilholz U., Schadendorf D., Nagorsen D., Schmittel A., Thiel E., and Scheibenbogen C. High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma. Int. J. Cancer 87 (2000) 659-664
2. Whiteside T.L., and Parmiani G. Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol. Immunother. 39 (1994) 15-21
3. Whiteside T.L. Tumor-infiltrating lymphocytes in human solid tumors. Immunol. Ser. 61 (1994) 137-148
4. Pawelec G. Tumour escape from the immune response. Cancer Immunol. Immunother. 53 (2004) 843
5. Lockhart D.C., Chan A.K., Mak S., Joo H.G., Daust H.A., Carritte A., Douville C.C., Goedegebuure P.S., and Eberlein T.J. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma. Surgery 129 (2001) 749-756
6. Whiteside T.L. Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?. Cancer Immunol. Immunother. 53 (2004) 865-878
7. Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4 (2004) 675-687
8. Reichert T.E., Rabinowich H., Johnson J.T., and Whiteside T.L. Mechanisms responsible for signaling and functional defects. J. Immunother. 21 (1998) 295-306
9. van Oers N.S., Tohlen B., Malissen B., Moomaw C.R., Afendis S., and Slaughter C.A. The 21- and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations. Nat. Immunol. 1 (2000) 322-328
10. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
11. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275 (2000) 17221-17224
12. Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., and Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395 (1998) 82-86
13. Dustin M.L., and Chan A.C. Signaling takes shape in the immune system. Cell 103 (2000) 283-294
14. Davis D.M. Assembly of the immunological synapse for T cells and NK cells. Trends Immunol. 23 (2002) 356-363
15. Taylor D.D., Bender D.P., Gercel-Taylor C., Stanson J., and Whiteside T.L. Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients. Br. J. Cancer 84 (2001) 1624-1629
16. Valeri A.P., Perez-Blas M., Gutierrez A., Lopez-Santalla M., Aguilera N., Rodriguez-Juan C., Sala-Silveira L., Martin J., Lasa I., Muguerza J.M., Lopez A., Garcia-Sancho L., Granell J., and Martin-Villa J.M. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma. Cancer Immunol. Immunother. 52 (2003) 708-714
17. Tsygankov A.Y. Cell transformation by Herpesvirus saimiri. J. Cell Physiol. 203 (2005) 305-318
18. Rogler G., Daig R., Aschenbrenner E., Vogl D., Schlottmann K., Falk W., Gross V., Scholmerich J., and Andus T. Establishment of long-term primary cultures of human small and large intestinal epithelial cells. Lab. Invest. 78 (1998) 889-890
19. Biesinger B., Muller-Fleckenstein I., Simmer B., Lang G., Wittmann S., Platzer E., Desrosiers R.C., and Fleckenstein B. Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 89 (1992) 3116-3119
20. James S.P., and Zeitz M. Handbook of Mucosal Immunology (1994), Academic Press, NY, USA
21. Krishnan S., Nambiar M.P., Warke V.G., Fisher C.U., Mitchell J., Delaney N., and Tsokos G.C. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J. Immunol. 172 (2004) 7821-7831
22. Nambiar M.P., Enyedy E.J., Warke V.G., Krishnan S., Dennis G., Kammer G.M., and Tsokos G.C. Polymorphisms/mutations of TCR-zeta-chain promoter and 3′ untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3′ untranslated region in patients with systemic lupus erythematosus. J. Autoimmun. 16 (2001) 133-142
23. Rabinowich H., Banks M., Reichert T.E., Logan T.F., Kirkwood J.M., and Whiteside T.L. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin. Cancer Res. 2 (1996) 1263-1274
24. De Paola F., Ridolfi R., Riccobon A., Flamini E., Barzanti F., Granato A.M., Mordenti G.L., Medri L., Vitali P., and Amadori D. Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2. Br. J. Cancer 88 (2003) 320-326
25. Rodriguez P.C., Zea A.H., and Ochoa A.C. Mechanisms of tumor evasion from the immune response. Cancer Chemother. Biol. Response Modif. 21 (2003) 351-364
26. Mizoguchi H., O'Shea J.J., Longo D.L., Loeffler C.M., McVicar D.W., and Ochoa A.C. Alterations in signal transduction molecule in T lymphocytes from tumor-bearing mice. Science 11 (1992) 1795-1798
27. Kim C.W., Choi S.H., Chung E.J., Lee M.J., Byun E.K., Ryu M.H., and Bang Y.J. Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients. Pathobiology 67 (1999) 123-128
28. Finke J.H., Zea A.H., Stanley J., Longo D.L., Mizoguchi H., Tubbs R.R., Wiltrout R.H., O'Shea J.J., Kudoh S., and Klein E. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53 (1993) 5613-5616
29. Rodriguez P.C., Zea A.H., DeSalvo J., Culotta K.S., Zabaleta J., Quiceno D.G., Ochoa J.B., and Ochoa A.C. l-Arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J. Immunol. 171 (2003) 1232-1239
30. Kono K., Salazar-Onfray F., Petersson M., Hansson J., Masucci G., Wasserman K., Nakazawa T., Anderson P., and Kiessling R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur. J. Immunol. 26 (1996) 1308-1313
31. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Okumura H., Matsumoto M., Miyazono F., Hokita S., and Aikou T. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res. 23 (2003) 4079-4083
32. Martin-Villa J.M., Ferre-Lopez S., Lopez-Suarez J.C., Perez-Blas M., Castellano-Tortajada G., Sanchez-Gomez F., and Arnaiz-Villena A. Successful in vitro immortalization of human intestinal mucosal lymphocytes with Herpesvirus saimiri. Tissue Antigens 52 (1998) 430-434
33. Reichert T.E., Day R., Wagner E.M., and Whiteside T.L. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res. 58 (1998) 5344-5347
34. Kolenko V., Wang Q., Riedy M.C., O'Shea J., Ritz J., Cathcart M.K., Rayman P., Tubbs R., Edinger M., Novick A., Bukowski R., and Finke J. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. J. Immunol. 159 (1997) 3057-3067
35. Lopez C.B., Rao T.D., Feiner H., Shapiro R., Marks J.R., and Frey A.B. Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes. Cell. Immunol. 190 (1998) 141-155
36. Sakkas L.I., Koussidis G., Avgerinos E., Gaughan J., and Platsoucas C.D. Decreased expression of the CD3zeta chain in T cells infiltrating the synovial membrane of patients with osteoarthritis. Clin. Diagn. Lab. Immunol. 11 (2004) 195-202
37. Nambiar M.P., Krishnan S., Warke V.G., and Tsokos G.C. TCR zeta-chain abnormalities in human systemic lupus erythematosus. Methods Mol. Med. 102 (2004) 49-72
38. Tsuzaka K., Fukuhara I., Setoyama Y., Yoshimoto K., Suzuki K., Abe T., and Takeuchi T. TCR zeta mRNA with an alternatively spliced 3′-untranslated region detected in systemic lupus erythematosus patients leads to the down-regulation of TCR zeta and TCR/CD3 complex. J. Immunol. 171 (2003) 2496-2503
39. Nambiar M.P., Enyedy E.J., Warke V.G., Krishnan S., Dennis G., Wong H.K., Kammer G.M., and Tsokos G.C. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA. Arthritis Rheum. 44 (2001) 1336-1350
40. Enyedy E.J., Nambiar M.P., Liossis S.N., Dennis G., Kammer G.M., and Tsokos G.C. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum. 44 (2001) 1114-1121
41. Bauer A., McConkey D.J., Howard F.D., Clayton L.K., Novick D., Koyasu S., and Reinherz E.L. Differential signal transduction via T-cell receptor CD3 zeta 2, CD3 zeta-eta, and CD3 eta 2 isoforms. Proc. Natl. Acad. Sci. USA 88 (1991) 3842-3846